Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01858740 · OUTCOME

Relapse Post-transplant

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children · Source last updated 2024-03-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Up to 5 years

What was measured

Relapse defined by the presence of malignant cells in marrow, peripheral blood, or extramedullary sites by histopathology

Groups in this outcome

Overall Study Participants

All participants in single arm study received CD45RA+ T cell depletion PBSC transplant and IV Methotrexate and tacrolimus for GVHD prophylaxis

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Overall Study Participants20

Reported measurements

Relapse in first 100 days
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Overall Study Participants0Not reportedNot reportedNot reportedNot reported
Relapse between day 101 to 6 months
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Overall Study Participants0Not reportedNot reportedNot reportedNot reported
Relapse between 6 months to 1 year
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Overall Study Participants2Not reportedNot reportedNot reportedNot reported
Relapse between 1 to 5 years
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Overall Study Participants1Not reportedNot reportedNot reportedNot reported
Total relapse in first 5 years
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Overall Study Participants3Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
    title
    Relapse in first 100 days
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        0
    title
    Relapse between day 101 to 6 months
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        2
    title
    Relapse between 6 months to 1 year
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        1
    title
    Relapse between 1 to 5 years
  5. categories
    1. measurements
      1. group Id
        OG000
        value
        3
    title
    Total relapse in first 5 years
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    units
    Participants
description
Relapse defined by the presence of malignant cells in marrow, peripheral blood, or extramedullary sites by histopathology
groups
  1. description
    All participants in single arm study received CD45RA+ T cell depletion PBSC transplant and IV Methotrexate and tacrolimus for GVHD prophylaxis
    id
    OG000
    title
    Overall Study Participants
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
Up to 5 years
title
Relapse Post-transplant
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice